Literature DB >> 27936497

Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease.

G Serena1,2, S Yan1, S Camhi1, S Patel1, R S Lima1, A Sapone1,3, M M Leonard1, R Mukherjee3, B J Nath4, K M Lammers1, A Fasano1,5.   

Abstract

Coeliac disease (CD) is an autoimmune enteropathy triggered by gluten and characterized by a strong T helper type 1 (Th1)/Th17 immune response in the small intestine. Regulatory T cells (Treg ) are CD4+ CD25++ forkhead box protein 3 (FoxP3+ ) cells that regulate the immune response. Conversely to its counterpart, FoxP3 full length (FL), the alternatively spliced isoform FoxP3 Δ2, cannot properly down-regulate the Th17-driven immune response. As the active state of CD has been associated with impairments in Treg cell function, we aimed at determining whether imbalances between FoxP3 isoforms may be associated with the disease. Intestinal biopsies from patients with active CD showed increased expression of FOXP3 Δ2 isoform over FL, while both isoforms were expressed similarly in non-coeliac control subjects (HC). Conversely to what we saw in the intestine, peripheral blood mononuclear cells (PBMC) from HC subjects did not show the same balance between isoforms. We therefore hypothesized that the intestinal microenvironment may play a role in modulating alternative splicing. The proinflammatory intestinal microenvironment of active patients has been reported to be enriched in butyrate-producing bacteria, while high concentrations of lactate have been shown to characterize the preclinical stage of the disease. We show that the combination of interferon (IFN)-γ and butyrate triggers the balance between FoxP3 isoforms in HC subjects, while the same does not occur in CD patients. Furthermore, we report that lactate increases both isoforms in CD patients. Collectively, these findings highlight the importance of the ratio between FoxP3 isoforms in CD and, for the first time, associate the alternative splicing process mechanistically with microbial-derived metabolites.
© 2017 British Society for Immunology.

Entities:  

Keywords:  Treg; autoimmunity; celiac disease; microbiome

Mesh:

Substances:

Year:  2017        PMID: 27936497      PMCID: PMC5290237          DOI: 10.1111/cei.12911

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  56 in total

Review 1.  Regulatory cell populations in the intestinal mucosa.

Authors:  Wendy A Goodman; Theresa T Pizarro
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

4.  Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.

Authors:  Fuping Zhang; Guangxun Meng; Warren Strober
Journal:  Nat Immunol       Date:  2008-10-12       Impact factor: 25.606

5.  Regulatory T-cell function is impaired in celiac disease.

Authors:  Marilena Granzotto; Sara dal Bo; Sara Quaglia; Alberto Tommasini; Elisa Piscianz; Erica Valencic; Fortunato Ferrara; Stefano Martelossi; Alessandro Ventura; Tarcisio Not
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

6.  FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1.

Authors:  Sang-Myeong Lee; Beixue Gao; Deyu Fang
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

7.  Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.

Authors:  Noemí Eiró; Salomé González-Reyes; Lucía González; Luis O González; Antonio Altadill; Alejandro Andicoechea; Manuel F Fresno-Forcelledo; Luis Rodrigo-Sáez; F J Vizoso
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

8.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

View more
  23 in total

Review 1.  Genetic and Environmental Contributors for Celiac Disease.

Authors:  Gloria Serena; Rosiane Lima; Alessio Fasano
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-18       Impact factor: 4.806

2.  Treg Cells and Epigenetic Regulation.

Authors:  Joseph A Bellanti; Dongmei Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Alternative splicing isoforms in health and disease.

Authors:  Hyoung Kyu Kim; Michael Huy Cuong Pham; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Pflugers Arch       Date:  2018-03-13       Impact factor: 3.657

4.  FOXP3 exon 2 controls Treg stability and autoimmunity.

Authors:  Jianguang Du; Qun Wang; Shuangshuang Yang; Si Chen; Yongyao Fu; Sabine Spath; Phillip Domeier; David Hagin; Stephanie Anover-Sombke; Maya Haouili; Sheng Liu; Jun Wan; Lei Han; Juli Liu; Lei Yang; Neel Sangani; Yujing Li; Xiongbin Lu; Sarath Chandra Janga; Mark H Kaplan; Troy R Torgerson; Steven F Ziegler; Baohua Zhou
Journal:  Sci Immunol       Date:  2022-06-24

5.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Thymosin β4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study.

Authors:  Pierpaolo Coni; Monica Piras; Anna Mateddu; Marco Piludu; Germano Orru; Alessandra Scano; Tiziana Cabras; Valentina Piras; Joanna Izabela Lachowicz; Mariusz Jaremko; Gavino Faa; Massimo Castagnola; Giuseppina Pichiri
Journal:  RSC Adv       Date:  2020-03-30       Impact factor: 4.036

Review 7.  Translational Chemistry Meets Gluten-Related Disorders.

Authors:  Karen M Lammers; Maria G Herrera; Veronica I Dodero
Journal:  ChemistryOpen       Date:  2018-02-27       Impact factor: 2.911

Review 8.  Alternative Splicing of FOXP3-Virtue and Vice.

Authors:  Reiner K W Mailer
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

Review 9.  Celiac Disease and the Thyroid: Highlighting the Roles of Vitamin D and Iron.

Authors:  Christina Starchl; Mario Scherkl; Karin Amrein
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.